医学
移植
粪便细菌疗法
艰难梭菌
粪便
肠易激综合征
肠道菌群
疾病
背景(考古学)
腹泻
多发性硬化
免疫学
胃肠病学
内科学
抗生素
生物
微生物学
古生物学
作者
Gaurav Tiwari,Anjali Paswan,Gaurav Tiwari,V Jaya Sankar Reddy,Mahesh Kumar Posa
出处
期刊:Chinese journal of applied physiology
[Chinese Medical Association]
日期:2025-01-01
卷期号:: e20250014-e20250014
标识
DOI:10.62958/j.cjap.2025.014
摘要
Fecal microbiota Transplantation (FMT), often referred to as stool transplantation, fecal transfusion, and fecal bacteria therapy, is considered one of the most medical innovations of the 20th century. Fecal microbiota Transplantation entails filtering and dilution of a healthy donor's feces before injecting it into the recipient's digestive system. In China, it was first administered orally in the fourth century for diarrhea and food poisoning under the name "Yellow Soup." It has recently been widely employed in a variety of clinical settings, including cases of Clostridium difficile infection that are recurring and resistant. By replacing the unhealthy intestinal microbiota with a healthy bacterial community, the FMT treatment aims to enhance the intestinal flora. It also looks at neurological conditions where alterations in gut microbiota are prevalent. We have discussed FMT in the context of its use in conditions affecting the nerve system, such as neurological and other conditions (multiple sclerosis, Parkinson's disease, Alzheimer's disease, stroke, epilepsy, Amyotrophic lateral sclerosis, Tourette syndrome, neuropathic pain, Huntington's diseases, etc.), as well as the role of gut microbiota in many neurological disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI